BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 30982286)

  • 1. [Be cautious to treat retinopathy of prematurity with anti-vascular endothelial growth factor pharmacotherapy].
    Liang JH; Cheng Y
    Zhonghua Yan Ke Za Zhi; 2019 Apr; 55(4):246-249. PubMed ID: 30982286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity.
    Sankar MJ; Sankar J; Mehta M; Bhat V; Srinivasan R
    Cochrane Database Syst Rev; 2016; 2():CD009734. PubMed ID: 26932750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of VEGF Inhibition in the Treatment of Retinopathy of Prematurity.
    Eldweik L; Mantagos IS
    Semin Ophthalmol; 2016; 31(1-2):163-8. PubMed ID: 26959143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Advances in Retinopathy of Prematurity].
    Xu XX; Wu YJ; Wu HY; Hu YX; Cheng Y; Yan L; Rao J; Wu N; Wu XR
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Apr; 41(2):261-266. PubMed ID: 31060684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The prevalence of retinopathy of prematurity in the mainland of China from 2008 to 2018].
    Wang L; Zhang ZF; Tao MZ; Li MH; Wang YS
    Zhonghua Yan Ke Za Zhi; 2021 May; 57(5):379-385. PubMed ID: 33915643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinopathy of Prematurity: Therapeutic Strategies Based on Pathophysiology.
    Cayabyab R; Ramanathan R
    Neonatology; 2016; 109(4):369-76. PubMed ID: 27251645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy and ROP: Going Back to the Basics.
    Shulman JP; Hartnett ME
    Asia Pac J Ophthalmol (Phila); 2018; 7(3):130-135. PubMed ID: 29701429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between systemic vascular endothelial growth factor and retinopathy of prematurity in premature infants: a systematic review.
    Kandasamy Y; Hartley L; Rudd D; Smith R
    Br J Ophthalmol; 2017 Jan; 101(1):21-24. PubMed ID: 27388246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hot Topics in Retinopathy of Prematurity.
    Tsui I; Chu A
    Pediatr Ann; 2017 Nov; 46(11):e415-e422. PubMed ID: 29131921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of intravitreal bevacizumab for zone-II retinopathy of prematurity.
    Karkhaneh R; Khodabande A; Riazi-Eafahani M; Roohipoor R; Ghassemi F; Imani M; Dastjani Farahani A; Ebrahimi Adib N; Torabi H
    Acta Ophthalmol; 2016 Sep; 94(6):e417-20. PubMed ID: 27009449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-vascular Endothelial Growth Factor Treatment of Retinopathy of Prematurity: Efficacy, Safety, and Anatomical Outcomes.
    Kang HG; Choi EY; Byeon SH; Kim SS; Koh HJ; Lee SC; Kim M
    Korean J Ophthalmol; 2018 Dec; 32(6):451-458. PubMed ID: 30549468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Plasma Cytokine Profile Changes in Bevacizumab-Treated Retinopathy of Prematurity Infants.
    Kong L; Demny AB; Sajjad A; Bhatt AR; Devaraj S
    Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):1649-54. PubMed ID: 27054517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinopathy of prematurity.
    Jordan CO
    Pediatr Clin North Am; 2014 Jun; 61(3):567-77. PubMed ID: 24852153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinopathy of prematurity-incidence today.
    Zin A; Gole GA
    Clin Perinatol; 2013 Jun; 40(2):185-200. PubMed ID: 23719304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinopathy of prematurity: New developments bring concern and hope.
    Darlow BA
    J Paediatr Child Health; 2015 Aug; 51(8):765-70. PubMed ID: 25757043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Aspects on the Treatment of Retinopathy of Prematurity: Currently Available Therapies and Emerging Novel Therapeutics.
    Ryu J
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinopathy of prematurity in Indonesia: Incidence and risk factors.
    Edy Siswanto J; Sauer PJ
    J Neonatal Perinatal Med; 2017; 10(1):85-90. PubMed ID: 28304327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reactivation of retinopathy of prematurity after ranibizumab treatment.
    Wong RK; Hubschman S; Tsui I
    Retina; 2015 Apr; 35(4):675-80. PubMed ID: 25768252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinopathy of Prematurity: Anti-VEGF treatment for ROP: which drug and what dose?
    Wallace DK
    J AAPOS; 2016 Dec; 20(6):476-478. PubMed ID: 27826044
    [No Abstract]   [Full Text] [Related]  

  • 20. Retinopathy of Prematurity among Very-Low-Birth-Weight Infants in Korea: Incidence, Treatment, and Risk Factors.
    Hwang JH; Lee EH; Kim EA
    J Korean Med Sci; 2015 Oct; 30 Suppl 1(Suppl 1):S88-94. PubMed ID: 26566363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.